Definitive Contract 75N95020C00033
- Not listed
- This is a firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH), to Molecular Devices LLC, a for-profit limited liability company and subsidiary of Danaher Corporation. The contract is for the repair of a FLIPR Penta molecular device, including shipping, with a ceiling value of $20,100.62 and a completion date of October 31, 2025. The contract does not have a set-aside...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Molecular Devices LLC, a subsidiary of Danaher Corporation. The $142,155.00 contract is for on-site performance assurance services for a FLIPR TETRA 96/384 molecular device system. The contract has an ultimate completion date of February 25, 2024 and was awarded on February 26, 2021. No set-aside was used for this award. Molecular Devices is a...
- This is a firm-fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Molecular Devices LLC for the provision of an ImageXpress Micro Confocal High Content Screening System. The $586,048.77 contract, which does not have a set-aside designation, has an ultimate completion date of May 15, 2017. Molecular Devices LLC, a division of Danaher Corporation, is a leading provider of bioanalytical measurement...
- This is a $24,540.00 firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse to Molecular Devices LLC, a division of Danaher Corporation. The contract is for the provision of specialized laboratory instruments, equipment, software, and related services to enable life sciences research and drug discovery. Molecular Devices LLC is a leading manufacturer of high-performance bioanalytical measurement solutions for pharmaceutical and...
- This is a firm-fixed-price purchase order awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Molecular Devices LLC, a division of Danaher Corporation, to procure a service agreement for a FLIPR TETRA. The total ceiling value of the contract is $123,203.00 and the ultimate completion date is March 31, 2028. There is no set-aside designation for this award. Molecular Devices LLC is a leading provider of high-performance bioanalytical measurement...
- This is a firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Molecular Devices LLC, a subsidiary of Danaher Corporation. The $208,187.00 contract provides an annual service agreement for Molecular Devices' FLIPR Tetra high-throughput cellular screening systems, which are used in NCATS' research on GPCR, ion channel, and stem cell projects with implications for pain and opioid...
- This federal contract award is a $98,981.40 firm-fixed-price purchase order to Molecular Devices LLC, a division of Danaher Corporation, by the National Institute on Drug Abuse (NIDA). The award is for the provision of specialized laboratory instruments, equipment, software, and related services to enable life sciences research and drug discovery. Molecular Devices LLC is a leading provider of high-performance bioanalytical measurement solutions, and has received numerous prime contract awards...
- This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Molecular Devices LLC, a subsidiary of Danaher Corporation. The $4,216 contract is for the provision of specialized laboratory instruments, equipment, software, and related services to enable life sciences research and drug discovery. Molecular Devices LLC is a leading provider of high-performance bioanalytical measurement...
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Child Health and Human Development to Molecular Devices LLC, a for-profit limited liability company that manufactures laboratory equipment and instruments. The $190,000.00 contract is for laboratory equipment, instruments, and supplies, with a completion date of November 9, 2019. The original solicitation was a simplified acquisition for...
- This firm-fixed-price purchase order for $41,597.00 was awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Molecular Devices LLC, a division of Danaher Corporation. The contract is for the delivery of a SpectraMax iD5 Standard Multimode Microplate Detection Platform, a specialized laboratory instrument used in life science research and drug discovery. Molecular Devices LLC is a manufacturer of high-performance...
Molecular Devices LLC was awarded a definitive contract valued at $658,099 by the National Institutes of Health National Institute on Drug Abuse to deliver one Molecular Devices FLIPR Penta high-throughput cellular screening system. The firm fixed price contract runs from September 24, 2020 through March 24, 2021. The prime contractor, Molecular Devices LLC, a division of Danaher Corporation, will provide the requested products and services to the NIH campus in Rockville, Maryland. The original solicitation sought a FLIPR Penta instrument with attachments and reagents enabling membrane potential assays in 96-, 384-, and 1536-well formats using an EMCCD camera and configurable pipettors to advance screening efforts at the National Center for the Advancement of Translational Sciences. There was no set-aside designation for this requirement.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Molecular Devices FLIPR Penta High-Throughput Cellular Screening System | NCATS-20-004407 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Award Notice 2/2 | 9/28/20, 1:09 PM | |
Molecular Devices FLIPR Penta High-Throughput Cellular Screening System | NCATS-20-004407 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Solicitation 1/2 | 9/11/20, 2:57 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $658.1k | 9/24/20 |